Patients Satisfaction With the Outcomes of Expensive Cytotoxic Agents
Prospective Questionnaire Based Observational Study Measuring the Degree of Patient's Satisfaction With the Outcomes of Expensive Cytotoxic Agents.
Sponsor: Ain Shams University
Listed as NCT02649725, this observational or N/A phase trial focuses on Patient's Satisfaction and remains ongoing. Sponsored by Ain Shams University, it has been updated 9 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Feb 2019 — Jan 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Feb 2019 [monthly]
Recruiting
▶ Show 4 earlier versions
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Jul 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jul 2017 [monthly]
Recruiting NA
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ain Shams University
- Benha University
- International Medical Center of Egypt.
- Kuwait Cancer Control Center
- Metghamr Cancer Center.
- Misr University for Science and Technology
For direct contact, visit the study record on ClinicalTrials.gov .